Technology innovations and economic forces are propelling the healthcare industry into new paradigms.
Value-based care is transforming how healthcare services are delivered, increasing the importance of data, analytics and workflow. Remote monitoring technology is blurring the line between consumer wellness and healthcare delivery while driving an explosion of new and valuable data. Genomics and “in-silico” testing enable precision-targeted therapeutics.
We focus our engagements on B2B tech & tech-enabled companies that serve three constituencies – life sciences companies, payers and provider organizations. Our healthcare tech team has a long history of successful outcomes across sellside, buyside and private capital, working with some of the leading companies in value-based care infrastructure, real-world evidence and technology-enabled research.